Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the α5β1 fibronectin receptor

Journal of Urology

Volumn 163, Issue 5, 2000, Pages 1553-1559

  Zhang, Guang Jian ^b   Crist, Scott A ^b   McKerrow, Amy K ^b   Xu, Yong ^b   Ladehoff, David C ^b   See, William A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

BCG; Bladder neoplasms; Fibronectin receptor; Interleukin 6

Indexed keywords

BCG VACCINE; FIBRONECTIN RECEPTOR; INTEGRIN; INTERLEUKIN 6; RECEPTOR SUBUNIT;

ARTICLE; AUTOCRINE EFFECT; CARCINOMA CELL; CELL ADHESION; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TRANSITIONAL CELL CARCINOMA;

EID: 0034005953     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67678-1     Document Type: Article

References (36)

1. Lamm, D. L. and Torti, F. M.: Bladder cancer, 1996. CA Cancer J Clin, 46: 93, 1996
2. Ratliff, T. L., Palmer, J. O., McGarr, J. A. and Brown, E. J.: Intravesical bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of bacillus Calmette-Guerin. Cancer Res, 47: 1762, 1987
3. Kavoussi, L. R., Brown, E. J., Ritchey, J. K. and Ratliff, T. L.: Fibronectin mediated Calmette-Guerin bacillus attachment to murine bladder mucosa: requirement for the expression of an antitumor response. J Clin Invest, 85: 62, 1990
4. Ratliff, T. L., Kavoussi, L. R. and Catalona, W. J.: Role of fibronectin in intravesical BCG therapy for superficial bladder cancer. J Urol, 139: 410, 1988
5. Hudson, M. A., Ritchey, J. K., Catalona, W. J., Brown, E. J. and Ratliff, T. L.: Comparison of the fibronectin-binding ability and antitumor activity of various microbacteria. Cancer Res, 50: 3843, 1990
6. Aslanzadeh, J., Brown, E. J., Quillin, S. T., Ritchey, J. K. and Ratliff, T. L.: Characterization of soluble fibronectin binding to Bacille Calmette-Guerin. J Gen Microbiol, 135: 2735, 1989
7. Peake, P., Gooley, A. and Britton, W. J.: Mechanism of interaction of the 85B secreted protein of microbacterium bovis with fibronectin. Infect Immun, 48: 28, 1993
8. Prescott, S., James, K., Hargreave, T. B., Chisholm, G. D. and Smyth, J. F.: Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol. 144: 1248, 1990
9. de Boer, E. C., De Jong, W. H., Steerenberg, P. A., Aarden, L. A., Tetteroo, E., De Groot, E. R., Van der Meijden, A. P., Vegt, P. D., Debruyne, F. M. and Ruitenberg, E. J.: Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer. Cancer Immunol Immunother, 34: 306, 1992
10. Balbay, D., Ozen, H., Ozkardes, H., Barut, A., Bakkaloglu, M., Tasar, C. and Remzi, D.: Detection of urinary interleukin-2, interleukin-2 receptor, and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy. Urology, 43: 187, 1994
11. Jackson, A. M., Alexandroff, A. B., Kelly, R. W., Skibinska, A., Esuvaranathan, K., Prescott, S., Chisholm, G. D. and James, K.: Changes in urinary cytokines and soluble intracellular adhesion molecule 1 (ICAM-1) in bladder cancer patients after BCG immunotherapy. Clin Exp Immunol, 99: 369, 1995
12. Patard, J. J., Muscatelli-Groux, B., Saint, F., Popov, Z., Maille, P., Abbou, C., and Chopin, D.: Evaluation of local immune response after intravesical bacille Calmette-Guerin treatment for superificial bladder cancer. Br J Urol, 78: 709, 1996
13. de Boer, E. C., Somogyi, L., de Ruiter, G. J., de Reijke, T. M., Kurth, K. H. and Schamhart, D. H.: Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer. Urol Res, 25: 31, 1997
14. de Reijke, T. M., Vos, P. C., de Boer, E. C., Bevers, R. F., de Muinck Keizer, W. H., Kurth, K. H. and Schamhart, D. H.: Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG). Urol Res, 21: 349, 1993
15. Sander, B., Damm, O., Gustafsson, B., Andersson, U. and Hakansson, L.: Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superificial bladder tumors treated with intravesical bacillus Calmette-Guerin. J Urol, 156: 536, 1996
16. Esuvaranathan, K., Alexandroff, A. B., McIntyre, M., Jackson, A. M., Prescott, S., Chisholm, G. D. and James, K.: Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. J Urol, 154: 572, 1995
17. Kaempfer, R., Gerez, L., Farbstein, H., Madar, L., Hirschman, O., Nussinovich, R. and Shapiro, A.: Prediction of response to treatment in superificial bladder carcinoma through pattern of interleukin-2 gene expression. J Clin Oncol, 14: 1178, 1996
18. de Reijke, T. M., de Boer, E. C., Kurth, K. H. and Schamhart, D. H.: Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability, and prognostic value. J Urol, 155: 477, 1996
19. Rabinowich, H., Sedlmayr, P., Herberman, R. B. and Whiteside, T. L.: Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to FN and laminin, and tumor necrosis factor-alpha/beta secretion. J Immunol, 150: 4844, 1993
20. Ohashi, H., Maeda, T., Mishima, H., Otori, T., Nishida, T. and Sekiguchi, K.: Upregulation of integrin alpha 5 beta 1 expression by interleukin-6 in rabbit corneal epithelial cells. Exp Cell Res, 218: 418, 1995
21. Elliott, A. Y., Bronson, D. L., Stein, N. and Finley, E. E.: In vitro cultivation of epithelial cells derived from tumors of the human urinary tract. Cancer Res, 36: 365, 1976
22. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162: 156, 1987
23. See, W. A., Rohlf, D. P. and Crist, S. A.: In vitro particulate adherence to fibronectin: correlation with in vivo particulate adherence to site of bladder injury. J Urol, 147: 1416, 1992
24. Mosmann, T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65: 55, 1983
25. Luo, Y., Szilvasi, A., Chen, X., DeWolf, W. C. and O'Donnell, M. A.: A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein. Clin Diagn Lab Immunol, 3: 761, 1996
26. Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S. and Kishimoto, T.: Structure and expression of the human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J, 6: 2939, 1987
27. Helfgott, D. C., May, L. T., Sthoeger, Z., Tamm, I. and Sehgal, P. B.: Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J Exp Med, 166: 1300, 1987
28. Ray, A., Tatter, S. B., May, L. T. and Seghal, P. B.: Activation of the human "beta 2-interferon/hepatocyte stimulating-factors/ interleukin-6" promoter by cytokines viruses and second messenger agonists. PNAS USA, 85: 6701, 1988
29. Jirik, F. R., Podor, T. J., Hirano, T., Kishimoto, T., Loskutoff, D. J., Carson, D. A. and Lotz, M.: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol, 142: 144, 1989
30. Seghal, P. B., Wang, L., Rayanade, R., Pan, H. and Margulies, L.: Interleukin-6 type cytokines. Ann NY Acad Sci, 762: 1, 1995
31. Meyers, F. J., Gumerlock, P. H., Kawasaki, E. S., Wang, A. M., de Vere White, R. W. and Erlich, H. A.: Bladder cancer human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer, 67: 2087, 1991
32. Seguchi, T., Yokokawa, K., Sugao, H., Nakano, E., Sonoda, T. and Okuyama, A.: Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol, 148: 791, 1992
33. Bevers, R. F., DeBoer, E. C., Kurth, K. H. and Schamhant, D. H.: BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell line. Eur Cytokine Network, 9: 181, 1998
34. Alexandroff, A. B., Black, J., Esuvaranathan, K. and James, K.: Antiproliferative effect of IL-6 on transitional cell carcinoma of the bladder. Insight into mechanisms of bacillus Calmette-Guerin immunotherapy. Biochem Soc Trans, 25: 270S, 1997
35. Okamoto, M., Hattori, K. and Oyasu, R.: Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer, 72: 149, 1997
36. Liebert, M., Washington, R., Stein, J., Wedemeyer, G. and Grossman, H. B.: Expression of the VLA beta-1 integrin family in bladder cancer. Am J Pathol, 144: 1016, 1994